Patent · US Active

Alpha-herpesvirus insensitive monoclonal cell strain, and preparation method therefor and use thereof

US12331321B1 · kind B1 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2024
Grant dateJun 17, 2025
Priority date
Expiry dateNov 29, 2044

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure discloses an α-herpesvirus insensitive monoclonal cell strain, and a preparation method therefor and use thereof, belonging to the technical field of biomedicine. In order to perform targeted research of intercellular transmission of an α-herpesvirus and an action mechanism thereof, the present disclosure discloses the α-herpesvirus insensitive monoclonal cell strain. The cell strain is named as a human liver cancer continuous cell line Huh7-C10 and has a potential of being applied to developing a new generation of enhanced oncolytic herpesvirus and single-round infection attenuated live vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.